[go: up one dir, main page]

AR073972A2 - Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas - Google Patents

Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas

Info

Publication number
AR073972A2
AR073972A2 ARP090104109A ARP090104109A AR073972A2 AR 073972 A2 AR073972 A2 AR 073972A2 AR P090104109 A ARP090104109 A AR P090104109A AR P090104109 A ARP090104109 A AR P090104109A AR 073972 A2 AR073972 A2 AR 073972A2
Authority
AR
Argentina
Prior art keywords
menopause
osteoporosis
prevention
treatment
carencies
Prior art date
Application number
ARP090104109A
Other languages
English (en)
Inventor
Jean-Louis Thomas
Michel Lanquetin
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9496456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR073972(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of AR073972A2 publication Critical patent/AR073972A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Una composicion farmacéutica para el tratamiento de carencias estrogénicas en la menopausia, que comprende una composicion estroprogestativa la cual comprende (i) de 0,5 a 3 mg de un estrogeno seleccionado del grupo constituido por estradiol libre, estradiol esterificado y estrogenos conjugados equinos, (ii) de 1,5 a 3,75 mg de acetato de nomegestrol y (iii) excipientes farmacéuticos adecuados para una administracion oral. Una composicion farmacéutica para la prevencion de la osteoporosis en mujeres menopáusicas, que comprende una composicion estroprogestativa la cual comprende (i) de 0,5 a 3 mg, de un estrogeno seleccionado del grupo constituido por estradiol libre, estradiol esterificado y estrogenos conjugados equinos, (ii) de 1,5 a 3,75 mg de acetato de nomegestrol y (iii) excipientes farmacéuticos adecuados para una administracion oral.
ARP090104109A 1996-10-08 2009-10-26 Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas AR073972A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9612239A FR2754179B1 (fr) 1996-10-08 1996-10-08 Nouvelle composition hormononale et son utilisation

Publications (1)

Publication Number Publication Date
AR073972A2 true AR073972A2 (es) 2010-12-15

Family

ID=9496456

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP970104638A AR009113A1 (es) 1996-10-08 1997-10-08 UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA
ARP090104109A AR073972A2 (es) 1996-10-08 2009-10-26 Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP970104638A AR009113A1 (es) 1996-10-08 1997-10-08 UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA

Country Status (38)

Country Link
US (4) US6831073B1 (es)
EP (2) EP0956022B1 (es)
JP (1) JP4883542B2 (es)
KR (2) KR100782638B1 (es)
CN (3) CN104706641A (es)
AP (1) AP1171A (es)
AR (2) AR009113A1 (es)
AT (2) ATE238057T1 (es)
AU (1) AU745571B2 (es)
BR (1) BR9712274A (es)
CA (1) CA2268358C (es)
CL (1) CL2011000017A1 (es)
CZ (1) CZ298402B6 (es)
DE (3) DE69737373T2 (es)
DK (2) DK0956022T3 (es)
DZ (1) DZ2327A1 (es)
ES (2) ES2198006T3 (es)
FR (2) FR2754179B1 (es)
HK (1) HK1210708A1 (es)
HU (2) HU227450B1 (es)
ID (1) ID21569A (es)
IL (1) IL129194A (es)
LU (1) LU91932I2 (es)
MA (1) MA24370A1 (es)
MY (1) MY128482A (es)
NO (3) NO324357B1 (es)
NZ (1) NZ334876A (es)
OA (1) OA11033A (es)
PL (1) PL192979B1 (es)
PT (2) PT1334725E (es)
RU (1) RU2274450C2 (es)
SK (2) SK285455B6 (es)
TN (1) TNSN97164A1 (es)
TR (1) TR199900764T2 (es)
TW (1) TW491704B (es)
WO (1) WO1998015279A1 (es)
YU (1) YU18099A (es)
ZA (1) ZA979011B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4344462C2 (de) 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO2001030355A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030356A1 (fr) * 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation
FR2814074B1 (fr) * 2000-09-15 2003-03-07 Theramex Nouvelles compositions estro-progestatives topiques a effet systemique
FR2823976A1 (fr) * 2001-04-25 2002-10-31 Theramex Nouvelle composition hormonale et son utilisation
GT200500315A (es) * 2004-11-02 2006-06-06 Formas de dosificacion oral solidas que contienen una dosis baja de estradiol
PE20081895A1 (es) * 2007-03-26 2009-01-26 Theramex Regimen anticonceptivo oral
RU2332219C1 (ru) * 2007-03-30 2008-08-27 Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА) Средство для модуляции плотности н2-гистаминовых рецепторов сердца при менопаузе
US20080293683A1 (en) * 2007-05-24 2008-11-27 University Of Kansas Medical Center Hormone Replacement Therapy
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
US10413504B2 (en) 2013-12-11 2019-09-17 Merck Sharp & Dohme Corp. Intravaginal ring drug delivery system
US10596103B2 (en) 2013-12-11 2020-03-24 Merek Sharp & Dohme B.V. Drug delivery system for delivery of anti-virals
CA3194580A1 (en) * 2020-10-16 2021-11-18 Mitra BOOLELL Use of combined oral contraceptives containing nomegestrol acetate and estradiol
KR102744791B1 (ko) 2022-07-05 2024-12-19 주식회사 이음정보 소멸특허 관리 및 특허거래 시스템

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3271392A (en) * 1965-09-14 1966-09-06 American Home Prod 17alpha-[3'-furyl]-estrogens
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4826831A (en) 1983-08-05 1989-05-02 Pre Jay Holdings Limited Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
JPS61243059A (ja) * 1985-04-19 1986-10-29 Konishi Kagaku Kogyo Kk 高純度４，４′−ジヒドロキシジフエニルスルホンの製造法
ZA87332B (en) 1986-02-27 1987-08-26 Warner Lambert Co Compositions containing fixed combinations
US5208225A (en) * 1986-02-27 1993-05-04 Warner-Lambert Company Compositions containing fixed combinations
US5145682A (en) * 1986-05-30 1992-09-08 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for postmenopausal syndrome treatment and process for administration
DK174724B1 (da) 1986-07-15 2003-10-06 Wyeth Corp Anvendelse af et præparat omfattende et østrogen og et progestogen til fremstilling af en dosisform til tilvejebringelse af hormonerstatningsterapi og kontraception til kvinder i præmenopausen samt pakning til tilvejebringelse af præparatet
CA1332227C (en) 1987-09-24 1994-10-04 Robert F. Casper Oral contraceptive formulation
US5108995A (en) * 1987-09-24 1992-04-28 Jencap Research Ltd. Hormone preparation and method
US5276022A (en) * 1987-09-24 1994-01-04 Jencap Research Ltd. Hormone preparation and method
ATE209919T1 (de) * 1987-09-24 2001-12-15 Jencap Res Ltd Oestrogen und progestin enthaltende verhütungspackungen
US5256421A (en) * 1987-09-24 1993-10-26 Jencap Research Ltd. Hormone preparation and method
HUT52382A (en) 1988-03-14 1990-07-28 Sandoz Ag Process for producing pharmaceutical compositions comprising as active ingredient unsubstituted progestin in 19-position and estrogen in the given case
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US6150343A (en) 1993-06-30 2000-11-21 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
US5552394A (en) * 1994-07-22 1996-09-03 The Medical College Of Hampton Roads Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy
US6613757B1 (en) 1994-09-22 2003-09-02 Board Of Regents, The University Of Texas System Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
SE9403389D0 (sv) 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
FR2737411B1 (fr) * 1995-08-01 1997-10-17 Theramex Nouveaux medicaments hormonaux et leur utilisation pour la correction des carences estrogeniques
DE19540253C2 (de) 1995-10-28 1998-06-04 Jenapharm Gmbh Mehrphasenpräparat zur Kontrazeption auf der Basis natürlicher Estrogene
DE19549264A1 (de) * 1995-12-23 1997-06-26 Schering Ag Verfahren und Kit zur Kontrazeption
WO1997041870A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
AU2746097A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
AU2926797A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
WO1997041871A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1997041868A1 (en) 1996-05-08 1997-11-13 American Home Products Corporation Oral contraceptive
WO1998004266A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Oral contraceptive
AU3888597A (en) 1996-07-26 1998-02-20 American Home Products Corporation Oral contraceptive
US5888543A (en) * 1996-07-26 1999-03-30 American Home Products Corporation Oral contraceptives
PT921804E (pt) 1996-07-26 2004-01-30 Wyeth Corp Metodo contraceptivo bifasico e conjunto ("kit") compreendendo uma combinacao de uma progestina e um estrogenio
PT917466E (pt) 1996-07-26 2004-12-31 Wyeth Corp Contraceptivo oral
WO1998004267A1 (en) 1996-07-26 1998-02-05 American Home Products Corporation Progestin/estrogen oral contraceptive
FR2754179B1 (fr) * 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
DE19705229C2 (de) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Verwendung von drei Hormonkomponenten zur hormonalen Kontrazeption zur Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
US5898032A (en) 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
DE69827017T2 (de) 1997-08-27 2006-03-09 Ortho-Mcneil Pharmaceutical, Inc. Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
JP2001516720A (ja) 1997-09-12 2001-10-02 アメリカン・ホーム・プロダクツ・コーポレイション プロゲスチン／エストロゲンからなる第一相とプロゲスチンからなる第二相とを有する経口避妊薬製剤
WO2001030356A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Composition hormonale a base d'un progestatif et d'un estrogene et son utilisation

Also Published As

Publication number Publication date
OA11033A (fr) 2003-03-06
DE122012000010I1 (de) 2012-04-19
SK285056B6 (sk) 2006-05-04
ATE353652T1 (de) 2007-03-15
KR20000048981A (ko) 2000-07-25
LU91932I2 (fr) 2012-03-13
TW491704B (en) 2002-06-21
HU227450B1 (en) 2011-06-28
NO2017043I1 (no) 2017-08-08
MA24370A1 (fr) 1998-07-01
LU91932I9 (es) 2018-12-27
EP1334725A3 (fr) 2004-01-21
RU2274450C2 (ru) 2006-04-20
EP0956022B1 (fr) 2003-04-23
EP1334725A2 (fr) 2003-08-13
US6831073B1 (en) 2004-12-14
AR009113A1 (es) 2000-03-08
DK1334725T3 (da) 2007-06-11
ATE238057T1 (de) 2003-05-15
AU4627397A (en) 1998-05-05
JP4883542B2 (ja) 2012-02-22
MY128482A (en) 2007-02-28
TR199900764T2 (xx) 1999-07-21
EP1334725B1 (fr) 2007-02-14
DE69721314T2 (de) 2004-02-12
FR12C0005I2 (fr) 2016-06-24
DE69737373D1 (de) 2007-03-29
US20040220163A1 (en) 2004-11-04
CA2268358C (fr) 2010-04-20
CN101229173A (zh) 2008-07-30
PL332610A1 (en) 1999-09-27
AP9901500A0 (en) 1999-06-30
CL2011000017A1 (es) 2011-06-24
ES2282539T3 (es) 2007-10-16
DE69721314D1 (de) 2003-05-28
HUS1200002I1 (hu) 2016-08-29
PT1334725E (pt) 2007-05-31
US7749987B2 (en) 2010-07-06
TNSN97164A1 (fr) 1999-12-31
CN104706641A (zh) 2015-06-17
IL129194A0 (en) 2000-02-17
CZ298402B6 (cs) 2007-09-19
JP2002509524A (ja) 2002-03-26
ZA979011B (en) 1998-06-03
DE69737373T2 (de) 2007-06-21
NO2017043I2 (no) 2019-01-25
US20070281912A1 (en) 2007-12-06
HUP9904508A3 (en) 2001-01-29
FR2754179A1 (fr) 1998-04-10
IL129194A (en) 2003-06-24
FR2754179B1 (fr) 1998-12-24
DK0956022T3 (da) 2003-08-04
PT956022E (pt) 2003-07-31
AP1171A (en) 2003-06-30
KR20060084864A (ko) 2006-07-25
CA2268358A1 (fr) 1998-04-16
BR9712274A (pt) 1999-08-31
US6906049B1 (en) 2005-06-14
CN1239893A (zh) 1999-12-29
YU18099A (sh) 2002-03-18
NO324357B1 (no) 2007-10-01
HUP9904508A2 (hu) 2000-06-28
CZ9901120A3 (cs) 2000-11-15
HK1210708A1 (en) 2016-05-06
NO2012002I2 (no) 2013-04-02
KR100782638B1 (ko) 2007-12-06
FR12C0005I1 (fr) 2012-02-24
EP0956022A1 (fr) 1999-11-17
ID21569A (id) 1999-06-24
NO991593D0 (no) 1999-03-31
NO991593L (no) 1999-06-07
SK285455B6 (sk) 2007-01-04
SK43899A3 (en) 1999-12-10
WO1998015279A1 (fr) 1998-04-16
PL192979B1 (pl) 2006-12-29
DZ2327A1 (fr) 2002-12-28
NO2012002I1 (no) 2012-01-24
AU745571B2 (en) 2002-03-21
NZ334876A (en) 2001-06-29
ES2198006T3 (es) 2004-01-16

Similar Documents

Publication Publication Date Title
AR073972A2 (es) Composiciones farmaceuticas para el tratamiento de carencias estrogenicas en la menopausia y para la prevencion de la osteoporosis en mujeres menopausicas
NZ516502A (en) Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG)
CA2356747A1 (en) Triphasic oral contraceptive
DE59510887D1 (de) Feste arzneiformen, enthaltend clathrate vom steroidalen sexualhormon ethinylestradiol
DE69804918D1 (de) Sehr niedrigdosiertes orales Kontrazeptiv mit weniger Menstruationsblutungen und verzögerter Wirkung
EA200201000A1 (ru) Гормон-заместительная терапия
MEP36008A (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za primjenu kao kontraceptivnog sredstva
HRP20090418T1 (hr) Farmaceutski pripravak koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate
BR0208163A (pt) Terapia de reposição hormonal
WO2003049744B1 (en) Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
RU2003107072A (ru) Применение гормональной композиции, содержащей сочетание эстрогена и прогестагена
AU2002338277B2 (en) Estrogen replacement therapy
MXPA02004084A (es) Nueva composicion hormonal y su utilizacion.
DE69731092D1 (de) Orales contrazeptivum
DE69724796D1 (de) Biphasische orale verhuetungsmethode und kit die eine kombination von progestin und eines oestrogens enthalten
KR890009407A (ko) 폐경기증세 및 골다공증의 치료를 위한 약학적 투여단위
AR033260A1 (es) Nueva composicion hormonal y su utilizacion
RU2000118225A (ru) Подкожное введение медроксипрогестерона ацетата для лечения менопаузы и эндометриоза
PROFILE KB 889, ORG OD 14, ORG OD14, Livial®, Livifem®, Boltin®
AR032371A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
DE4494826D2 (de) Oral estrogen wirksame Ester des 14alpha,15alpha-Methylen-estradiols
HRP20020666B1 (hr) Drospirenon za hormonsku nadomjesnu terapiju
MXPA99001793A (es) Sistema terapeutico percutaneo, con una combinacion de sustancia activa que contiene estriol
RU97106414A (ru) Применение комбинации простациклина с эстрогеном или прогестином для профилактики и лечения атеросклероза сосудов, включая преэклампсию, а также для лечения гипертензии и заместительной гормональной терапии
AU2008200820A1 (en) Estrogen replacement therapy

Legal Events

Date Code Title Description
FC Refusal